MoneyWorks4Me

Rubra Medicaments informs about trading window closure

28 Dec 2022 Evaluate
Rubra Medicaments has informed that Trading Window for dealing in the Company's Equity Shares will remain closed from Sunday, January 1, 2023 for all Designated Employees of the Company. The closure is in connection with the declaration of unaudited financial results of the Company for the quarter ending December 31, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers